Researchers halt ‘ineffective’ HIV vaccine trial

HIV trial volunteer
A participant in the South African HIV vaccine trial receives a shot at a clinic. (NIAID via YouTube)

A three-year-long clinical trial of an HIV vaccine in South Africa, funded in part by the Bill & Melinda Gates Foundation and managed by a consortium headquartered at Seattle’s Fred Hutchinson Cancer Research Center, has been put on hold because the vaccine was judged ineffective.

Get the news brief on GeekWire.

By Alan Boyle

Mastermind of Cosmic Log, contributor to GeekWire and Universe Today, author of "The Case for Pluto: How a Little Planet Made a Big Difference," past president of the Council for the Advancement of Science Writing.

Leave a Reply